Skip to main content
OpenTrials

Clinical trial condition

Lymphocytic Leukemia, Chronic

Explore clinical trials studying Lymphocytic Leukemia, Chronic. Study availability and eligibility vary by location and protocol.

28 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Lymphocytic Leukemia, Chronic trial results

Completed

A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia

NCT01609023

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • University General Hospital of Alexandroupolis; Haemotology Alexandroupoli, Greece
  • General Hospital of Athens Evangelismos; Hematology Athens, Greece
  • Laiko General Hospital of Athens; A Propedeutical Clinic of Internal Medicine Athens, Greece
  • Metropolitan Hospital; Hematology Dept Athens, Greece
View Trial Details
Completed

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

NCT01263704

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Haemek Medical Center; Hematology Department Afula, Israel
  • Soroka Medical Center; Hematology Deptartment Beersheba, Israel
  • Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel
  • Bnei-Zion Medical Center; Hematology Dept Haifa, Israel
View Trial Details
Completed

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

NCT02013817

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie Innsbruck, Austria
  • LKH Hochsteiermark; Abt. für Innere Medizin Leoben, Austria
  • Kh Der Barmherzigen Schwestern; Interne I X Linz, Austria
  • A.Ö. Krankenhaus Der Elisabethinen Linz; I. Interne Abt. Linz, Austria
View Trial Details
Completed

A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.

NCT00738374

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Uni Degli Studi Di Bari, Policlinico; Cattedra Di Ematologia,Dipart. Di Medicina Interna E Publica Bari, Apulia, Italy
  • Az. Osp. Pugliese; Dh Oncologico Catanzaro, Calabria, Italy
  • P.O. Annunziata; U.O. Ematologia Cosenza, Calabria, Italy
  • Ospedale Riuniti; Divisione Di Ematologia Reggio Calabria, Calabria, Italy
View all 20 locations
View Trial Details
Completed

A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)

NCT01414205

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Univ of Alabama at Birmingham; UAB Comprehensive Cancer Ctr Birmingham, Alabama, United States
  • Arizona Oncology Tucson, Arizona, United States
  • Arizona Clinical Research Ctr Tucson, Arizona, United States
  • University of California; Moores Cancer Center La Jolla, California, United States
View all 31 locations
View Trial Details
Completed

A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)

NCT01300247

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Huntsville, Alabama, United States
  • Duarte, California, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 18 locations
View Trial Details

Related conditions